KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medtronic (MDT) Restructuring Costs (2016 - 2025)

Historic Restructuring Costs for Medtronic (MDT) over the last 12 years, with Q4 2025 value amounting to $13.0 million.

  • Medtronic's Restructuring Costs fell 7173.91% to $13.0 million in Q4 2025 from the same period last year, while for Oct 2025 it was $239.0 million, marking a year-over-year decrease of 4838.01%. This contributed to the annual value of $267.0 million for FY2025, which is 1814.16% up from last year.
  • Per Medtronic's latest filing, its Restructuring Costs stood at $13.0 million for Q4 2025, which was down 7173.91% from $67.0 million recorded in Q3 2025.
  • Medtronic's Restructuring Costs' 5-year high stood at $300.0 million during Q2 2023, with a 5-year trough of $10.0 million in Q4 2021.
  • Moreover, its 5-year median value for Restructuring Costs was $77.0 million (2022), whereas its average is $89.8 million.
  • As far as peak fluctuations go, Medtronic's Restructuring Costs tumbled by 8969.07% in 2021, and later soared by 85000.0% in 2022.
  • Medtronic's Restructuring Costs (Quarter) stood at $10.0 million in 2021, then soared by 850.0% to $95.0 million in 2022, then fell by 4.21% to $91.0 million in 2023, then crashed by 49.45% to $46.0 million in 2024, then plummeted by 71.74% to $13.0 million in 2025.
  • Its Restructuring Costs was $13.0 million in Q4 2025, compared to $67.0 million in Q3 2025 and $113.0 million in Q2 2025.